Kimberly-Clark to Acquire Kenvue in $48.7 Billion Consumer Staples Deal

1 min read
Source: Bloomberg
Kimberly-Clark to Acquire Kenvue in $48.7 Billion Consumer Staples Deal
Photo: Bloomberg
TL;DR

Kimberly-Clark is acquiring Kenvue, the maker of Tylenol, for $40 billion, creating a leading health and wellness company with over $32 billion in revenue, despite legal and market challenges related to Tylenol's safety concerns and recent financial struggles of Kenvue.

Share this article

Want the full story? Read the original reporting

Read on Bloomberg